$GHDX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENOMIC HEALTH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GENOMIC HEALTH INC. Get notifications about new insider transactions in GENOMIC HEALTH INC for free.
Page: < prev 1 ... 17 18 19 20 21 22 23 24 25 ... 28 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 08 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 28.59 | 2,500 | 71,464 | 7,750 | 10.3 K to 7.8 K (-24.39 %) |
Dec 08 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 1.33 | 2,500 | 3,325 | 10,250 | 7.8 K to 10.3 K (+32.26 %) |
Dec 05 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 28.39 | 225 | 6,388 | 192,064 | 191.8 K to 192.1 K (+0.12 %) |
Dec 05 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 28.50 | 323 | 9,205 | 191,839 | 191.5 K to 191.8 K (+0.17 %) |
Dec 05 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 28.06 | 1,965 | 55,131 | 191,516 | 189.6 K to 191.5 K (+1.04 %) |
Dec 05 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 28.03 | 639 | 17,914 | 189,551 | 188.9 K to 189.6 K (+0.34 %) |
Dec 14 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 27.50 | 2,110 | 58,016 | 1,361,146 | 1.4 M to 1.4 M (-0.15 %) |
Dec 14 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 26.88 | 7,890 | 212,062 | 1,363,256 | 1.4 M to 1.4 M (-0.58 %) |
Dec 14 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 28.46 | 100 | 2,846 | 1,371,146 | 1.4 M to 1.4 M (-0.01 %) |
Dec 14 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 27.56 | 9,900 | 272,806 | 1,371,246 | 1.4 M to 1.4 M (-0.72 %) |
Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.39 | 1,385 | 39,320 | 1,306,281 | 1.3 M to 1.3 M (+0.11 %) |
Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.50 | 1,992 | 56,772 | 1,304,896 | 1.3 M to 1.3 M (+0.15 %) |
Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.06 | 12,123 | 340,128 | 1,302,904 | 1.3 M to 1.3 M (+0.94 %) |
Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.03 | 3,940 | 110,458 | 1,290,781 | 1.3 M to 1.3 M (+0.31 %) |
Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 27.33 | 26,537 | 725,256 | 1,286,841 | 1.3 M to 1.3 M (+2.11 %) |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Option Exercise | M | 9.39 | 5,000 | 46,950 | 0 | |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 26.07 | 5,000 | 130,328 | 392,778 | 397.8 K to 392.8 K (-1.26 %) |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Buy | M | 9.39 | 5,000 | 46,950 | 397,778 | 392.8 K to 397.8 K (+1.27 %) |
Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 28.39 | 8,390 | 238,192 | 6,901,703 | 6.9 M to 6.9 M (+0.12 %) |
Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 28.50 | 12,066 | 343,880 | 6,893,313 | 6.9 M to 6.9 M (+0.18 %) |
Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 28.06 | 73,430 | 2,060,181 | 6,881,247 | 6.8 M to 6.9 M (+1.08 %) |
Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 28.03 | 23,865 | 669,053 | 6,807,817 | 6.8 M to 6.8 M (+0.35 %) |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 25.88 | 384 | 9,938 | 188,912 | 188.5 K to 188.9 K (+0.20 %) |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 25.71 | 155 | 3,985 | 188,528 | 188.4 K to 188.5 K (+0.08 %) |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.03 | 2,044 | 53,206 | 188,373 | 186.3 K to 188.4 K (+1.10 %) |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 25.91 | 3,167 | 82,041 | 186,329 | 183.2 K to 186.3 K (+1.73 %) |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.88 | 47,998 | 1,242,179 | 6,783,952 | 6.7 M to 6.8 M (+0.71 %) |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.71 | 19,429 | 499,541 | 6,735,954 | 6.7 M to 6.7 M (+0.29 %) |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.03 | 46,328 | 1,205,927 | 6,716,525 | 6.7 M to 6.7 M (+0.69 %) |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.91 | 79,984 | 2,071,986 | 6,670,197 | 6.6 M to 6.7 M (+1.21 %) |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 25.88 | 1,618 | 41,874 | 1,260,304 | 1.3 M to 1.3 M (+0.13 %) |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 25.71 | 655 | 16,841 | 1,258,686 | 1.3 M to 1.3 M (+0.05 %) |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.03 | 1,628 | 42,377 | 1,258,031 | 1.3 M to 1.3 M (+0.13 %) |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 25.91 | 1,630 | 42,225 | 1,256,403 | 1.3 M to 1.3 M (+0.13 %) |
Nov 22 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 22.60 | 10,000 | 225,985 | 1,431,146 | 1.4 M to 1.4 M (-0.69 %) |
Nov 22 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 23.06 | 10,000 | 230,608 | 1,441,146 | 1.5 M to 1.4 M (-0.69 %) |
Nov 22 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Gift | G | 0.00 | 25,000 | 0 | 1,381,146 | 1.4 M to 1.4 M (-1.78 %) |
Nov 22 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Gift | G | 0.00 | 5,000 | 0 | 1,406,146 | 1.4 M to 1.4 M (-0.35 %) |
Nov 17 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 27.50 | 9,774 | 268,783 | 6,590,213 | 6.6 M to 6.6 M (+0.15 %) |
Nov 17 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 27.24 | 14,482 | 394,527 | 6,580,439 | 6.6 M to 6.6 M (+0.22 %) |
Nov 17 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 27.90 | 23,758 | 662,779 | 6,565,957 | 6.5 M to 6.6 M (+0.36 %) |
Nov 17 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 27.99 | 16,583 | 464,090 | 6,542,199 | 6.5 M to 6.5 M (+0.25 %) |
Nov 17 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 27.50 | 383 | 10,532 | 183,162 | 182.8 K to 183.2 K (+0.21 %) |
Nov 17 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 27.24 | 568 | 15,474 | 182,779 | 182.2 K to 182.8 K (+0.31 %) |
Nov 17 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 27.90 | 942 | 26,279 | 182,211 | 181.3 K to 182.2 K (+0.52 %) |
Nov 17 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 27.99 | 657 | 18,387 | 181,269 | 180.6 K to 181.3 K (+0.36 %) |
Nov 17 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 27.50 | 185 | 5,087 | 1,254,773 | 1.3 M to 1.3 M (+0.01 %) |
Nov 17 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 27.24 | 273 | 7,437 | 1,254,588 | 1.3 M to 1.3 M (+0.02 %) |
Nov 14 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 27.25 | 1,567 | 42,707 | 180,612 | 179 K to 180.6 K (+0.88 %) |
Nov 14 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 27.66 | 4,052 | 112,088 | 179,045 | 175 K to 179 K (+2.32 %) |
Nov 14 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.89 | 1,509 | 40,573 | 174,993 | 173.5 K to 175 K (+0.87 %) |
Nov 14 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.66 | 317 | 8,452 | 173,484 | 173.2 K to 173.5 K (+0.18 %) |
Nov 14 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.80 | 2,661 | 71,326 | 173,167 | 170.5 K to 173.2 K (+1.56 %) |
Nov 14 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 27.53 | 10,000 | 275,280 | 1,411,146 | 1.4 M to 1.4 M (-0.70 %) |
Nov 14 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 26.95 | 10,000 | 269,549 | 1,421,146 | 1.4 M to 1.4 M (-0.70 %) |
Nov 14 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 27.25 | 39,117 | 1,066,091 | 6,525,616 | 6.5 M to 6.5 M (+0.60 %) |
Nov 14 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 27.66 | 100,823 | 2,789,006 | 6,486,499 | 6.4 M to 6.5 M (+1.58 %) |
Nov 14 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.89 | 36,956 | 993,654 | 6,385,676 | 6.3 M to 6.4 M (+0.58 %) |
Nov 14 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.66 | 7,725 | 205,975 | 6,348,720 | 6.3 M to 6.3 M (+0.12 %) |
Nov 14 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.80 | 64,754 | 1,735,679 | 6,340,995 | 6.3 M to 6.3 M (+1.03 %) |
Nov 14 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.66 | 58 | 1,546 | 1,254,315 | 1.3 M to 1.3 M (0.00 %) |
Nov 14 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.80 | 484 | 12,973 | 1,254,257 | 1.3 M to 1.3 M (+0.04 %) |
Nov 07 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.20 | 60,162 | 1,576,431 | 6,276,241 | 6.2 M to 6.3 M (+0.97 %) |
Nov 07 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.28 | 72,209 | 1,897,602 | 6,216,079 | 6.1 M to 6.2 M (+1.18 %) |
Nov 07 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.78 | 55,920 | 1,441,461 | 6,143,870 | 6.1 M to 6.1 M (+0.92 %) |
Nov 07 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 24.49 | 20,267 | 496,258 | 6,087,950 | 6.1 M to 6.1 M (+0.33 %) |
Nov 07 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 24.42 | 954 | 23,296 | 6,067,683 | 6.1 M to 6.1 M (+0.02 %) |
Nov 08 2011 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Buy | J | 0.00 | 131 | 0 | 50,035 | 49.9 K to 50 K (+0.26 %) |
Nov 09 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 1.33 | 2,500 | 3,325 | 60,368 | |
Nov 09 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 26.60 | 2,500 | 66,506 | 7,750 | 10.3 K to 7.8 K (-24.39 %) |
Nov 09 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 1.33 | 2,500 | 3,325 | 10,250 | 7.8 K to 10.3 K (+32.26 %) |
Nov 07 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.20 | 2,538 | 66,503 | 170,506 | 168 K to 170.5 K (+1.51 %) |
Nov 07 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.28 | 3,046 | 80,047 | 167,968 | 164.9 K to 168 K (+1.85 %) |
Nov 07 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 25.78 | 2,365 | 60,963 | 164,922 | 162.6 K to 164.9 K (+1.45 %) |
Nov 07 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 24.49 | 857 | 20,985 | 162,557 | 161.7 K to 162.6 K (+0.53 %) |
Nov 07 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 24.42 | 41 | 1,001 | 161,700 | 161.7 K to 161.7 K (+0.03 %) |
Oct 31 2011 | GHDX | GENOMIC HEALTH INC | LIVINGSTON RANDALL S | Director | Option Exercise | M | 1.33 | 2,000 | 2,653 | 11,346 | |
Oct 31 2011 | GHDX | GENOMIC HEALTH INC | LIVINGSTON RANDALL S | Director | Sell | S | 22.08 | 2,000 | 44,160 | 6,149 | 8.1 K to 6.1 K (-24.54 %) |
Oct 31 2011 | GHDX | GENOMIC HEALTH INC | LIVINGSTON RANDALL S | Director | Buy | M | 1.33 | 2,000 | 2,653 | 8,149 | 6.1 K to 8.1 K (+32.53 %) |
Nov 07 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 24.49 | 115 | 2,816 | 1,253,773 | 1.3 M to 1.3 M (+0.01 %) |
Nov 07 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 24.42 | 5 | 122 | 1,253,658 | 1.3 M to 1.3 M (0.00 %) |
Oct 26 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Option Exercise | M | 9.39 | 5,000 | 46,950 | 5,000 | |
Oct 26 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 21.76 | 5,000 | 108,822 | 392,778 | 397.8 K to 392.8 K (-1.26 %) |
Oct 26 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Buy | M | 9.39 | 5,000 | 46,950 | 397,778 | 392.8 K to 397.8 K (+1.27 %) |
Oct 07 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 1.33 | 5,000 | 6,650 | 62,868 | |
Oct 07 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 22.31 | 5,000 | 111,546 | 7,750 | 12.8 K to 7.8 K (-39.22 %) |
Oct 07 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 1.33 | 5,000 | 6,650 | 12,750 | 7.8 K to 12.8 K (+64.52 %) |
Oct 04 2011 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Grant | A | 21.98 | 454 | 9,979 | 1,218 | 764 to 1.2 K (+59.42 %) |
Oct 04 2011 | GHDX | GENOMIC HEALTH INC | MYERS WOODROW A JR | Director | Grant | A | 21.98 | 454 | 9,979 | 1,218 | 764 to 1.2 K (+59.42 %) |
Oct 04 2011 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 21.98 | 454 | 9,979 | 49,903 | 49.4 K to 49.9 K (+0.92 %) |
Oct 04 2011 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Grant | A | 21.98 | 454 | 9,979 | 1,218 | 764 to 1.2 K (+59.42 %) |
Sep 14 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 20.90 | 10,000 | 209,032 | 1,451,146 | 1.5 M to 1.5 M (-0.68 %) |
Sep 14 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 20.72 | 10,000 | 207,237 | 1,461,146 | 1.5 M to 1.5 M (-0.68 %) |
Sep 29 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Option Exercise | M | 9.39 | 5,000 | 46,950 | 10,000 | |
Sep 29 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 19.65 | 5,000 | 98,231 | 392,778 | 397.8 K to 392.8 K (-1.26 %) |
Sep 29 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Buy | M | 9.39 | 5,000 | 46,950 | 397,778 | 392.8 K to 397.8 K (+1.27 %) |
Sep 08 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 1.33 | 2,500 | 3,325 | 67,868 | |
Sep 08 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 22.08 | 2,500 | 55,209 | 7,750 | 10.3 K to 7.8 K (-24.39 %) |
Sep 08 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 1.33 | 2,500 | 3,325 | 10,250 | 7.8 K to 10.3 K (+32.26 %) |
Aug 26 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Option Exercise | M | 9.39 | 5,000 | 46,950 | 15,000 | |
Aug 26 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 23.02 | 5,000 | 115,109 | 392,778 | 397.8 K to 392.8 K (-1.26 %) |
Aug 26 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Buy | M | 9.39 | 5,000 | 46,950 | 397,778 | 392.8 K to 397.8 K (+1.27 %) |
Aug 10 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 1.33 | 2,500 | 3,325 | 70,368 | |
Aug 10 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 25.26 | 2,500 | 63,142 | 7,750 | 10.3 K to 7.8 K (-24.39 %) |
Aug 10 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 1.33 | 2,500 | 3,325 | 10,250 | 7.8 K to 10.3 K (+32.26 %) |
Aug 12 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 24.40 | 10,000 | 243,979 | 1,471,146 | 1.5 M to 1.5 M (-0.68 %) |
Aug 12 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 24.48 | 10,000 | 244,751 | 1,481,146 | 1.5 M to 1.5 M (-0.67 %) |
Jul 29 2011 | GHDX | GENOMIC HEALTH INC | LIVINGSTON RANDALL S | Director | Option Exercise | M | 1.33 | 2,000 | 2,653 | 13,346 | |
Jul 29 2011 | GHDX | GENOMIC HEALTH INC | LIVINGSTON RANDALL S | Director | Sell | S | 26.45 | 2,000 | 52,907 | 6,149 | 8.1 K to 6.1 K (-24.54 %) |
Jul 29 2011 | GHDX | GENOMIC HEALTH INC | LIVINGSTON RANDALL S | Director | Buy | M | 1.33 | 2,000 | 2,653 | 8,149 | 6.1 K to 8.1 K (+32.53 %) |
Jul 27 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Option Exercise | M | 9.39 | 3,355 | 31,503 | 20,000 | |
Jul 27 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Option Exercise | M | 9.39 | 1,645 | 15,447 | 23,355 | |
Jul 27 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 27.61 | 5,000 | 138,053 | 392,778 | 397.8 K to 392.8 K (-1.26 %) |
Jul 27 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Buy | M | 9.39 | 5,000 | 46,950 | 397,778 | 392.8 K to 397.8 K (+1.27 %) |
Jul 08 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 1.33 | 5,000 | 6,650 | 72,868 | |
Jul 08 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 27.74 | 5,000 | 138,686 | 7,750 | 12.8 K to 7.8 K (-39.22 %) |
Jul 08 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 1.33 | 5,000 | 6,650 | 12,750 | 7.8 K to 12.8 K (+64.52 %) |
Jul 13 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 27.17 | 10,000 | 271,653 | 1,491,146 | 1.5 M to 1.5 M (-0.67 %) |
Jul 13 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 27.56 | 10,000 | 275,558 | 1,501,146 | 1.5 M to 1.5 M (-0.66 %) |
Jul 06 2011 | GHDX | GENOMIC HEALTH INC | MYERS WOODROW A JR | Director | Grant | A | 27.91 | 358 | 9,992 | 764 | 406 to 764 (+88.18 %) |
Jul 06 2011 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Grant | A | 27.91 | 358 | 9,992 | 764 | 406 to 764 (+88.18 %) |
Jul 06 2011 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Grant | A | 27.91 | 358 | 9,992 | 764 | 406 to 764 (+88.18 %) |
Jul 06 2011 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 27.91 | 358 | 9,992 | 49,449 | 49.1 K to 49.4 K (+0.73 %) |
Jul 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Sell | J | 0.00 | 7,280 | 0 | 187,135 | 194.4 K to 187.1 K (-3.74 %) |
Jul 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | J | 0.00 | 7,280 | 0 | 6,066,729 | 6.1 M to 6.1 M (+0.12 %) |
Jun 27 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Option Exercise | M | 9.39 | 5,000 | 46,950 | 25,000 | |
Jun 27 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 27.12 | 5,000 | 135,581 | 392,778 | 397.8 K to 392.8 K (-1.26 %) |
Jun 27 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Buy | M | 9.39 | 5,000 | 46,950 | 397,778 | 392.8 K to 397.8 K (+1.27 %) |
Jun 16 2011 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 25.91 | 1,000 | 25,909 | 18,900 | 19.9 K to 18.9 K (-5.03 %) |
Jun 14 2011 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | A | 25.79 | 8,250 | 212,768 | 8,250 | |
Jun 14 2011 | GHDX | GENOMIC HEALTH INC | MYERS WOODROW A JR | Director | Option Exercise | A | 25.79 | 8,250 | 212,768 | 8,250 | |
Jun 14 2011 | GHDX | GENOMIC HEALTH INC | LIVINGSTON RANDALL S | Director | Option Exercise | A | 25.79 | 8,250 | 212,768 | 8,250 | |
Jun 14 2011 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Option Exercise | A | 25.79 | 8,250 | 212,768 | 8,250 | |
Jun 14 2011 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Option Exercise | A | 25.79 | 8,250 | 212,768 | 8,250 | |
Jun 14 2011 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Option Exercise | A | 25.79 | 8,250 | 212,768 | 8,250 | |
Jun 14 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 25.37 | 10,000 | 253,698 | 1,511,146 | 1.5 M to 1.5 M (-0.66 %) |
Jun 14 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 26.01 | 10,000 | 260,140 | 1,521,146 | 1.5 M to 1.5 M (-0.65 %) |
Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.35 | 1,864 | 49,116 | 6,059,449 | 6.1 M to 6.1 M (+0.03 %) |
Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.30 | 5,996 | 157,679 | 6,057,585 | 6.1 M to 6.1 M (+0.10 %) |
Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.25 | 82,031 | 2,153,314 | 6,051,589 | 6 M to 6.1 M (+1.37 %) |
Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.10 | 11,415 | 297,932 | 5,969,558 | 6 M to 6 M (+0.19 %) |
Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.11 | 8,746 | 228,388 | 5,958,143 | 5.9 M to 6 M (+0.15 %) |
Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.15 | 24,402 | 638,112 | 5,949,397 | 5.9 M to 5.9 M (+0.41 %) |
Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.14 | 25,435 | 664,924 | 5,924,995 | 5.9 M to 5.9 M (+0.43 %) |
Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.17 | 43,763 | 1,145,212 | 5,899,560 | 5.9 M to 5.9 M (+0.75 %) |
Jun 09 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.35 | 35 | 922 | 161,659 | 161.6 K to 161.7 K (+0.02 %) |
Jun 09 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.30 | 112 | 2,945 | 161,624 | 161.5 K to 161.6 K (+0.07 %) |
Jun 09 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.25 | 1,524 | 40,005 | 161,512 | 160 K to 161.5 K (+0.95 %) |
Jun 09 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.10 | 273 | 7,125 | 159,988 | 159.7 K to 160 K (+0.17 %) |
Jun 09 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.11 | 209 | 5,458 | 159,715 | 159.5 K to 159.7 K (+0.13 %) |